Healthcare -
Medical - Devices - NASDAQ - US
$ 10.27
1.28 %
$ 671 M
Market Cap
-16.84
P/E
Price Target
Average
--0.19%
Revenue Forecast
Estimate
15.41%
EBIT
Estimate
56.61%
Net Income
Estimate
130.48%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Bioventus Inc.
Wall Street analysts predict an average 1-year price target for BVS of $10.2 , with forecasts ranging from
a
low of
$8 to a high of $12 .
BVS Lowest Price Target
Wall Street Target
8 USD
-22.10%
BVS Average Price Target
Wall Street Target
10.2 USD
-0.19%
BVS Highest Price Target
Wall Street Target
12 USD
16.85%
REVENUE FORECAST
Revenue Forecast Chart BVS
EBIT FORECAST
EBIT Forecast Chart BVS
NET INCOME FORECAST
Net Income Chart BVS